LQDA - רווח נקי למניה (EPS TTM) Liquidia Corp

Liquidia Corporation (LQDA) liquidity relies on low-cost capsule production, while geopolitics complicates component logistics. The launch of Yutrepia via the circumvention of patent restrictions has become a key driver. The company's annual net profit per share on the GURU.Markets chart demonstrates a smooth trajectory, where this metric equals -1.23, helping investors avoid risks associated with sharp market volatility.
Liquidia Technologies - פילוחים אנליטיים ומדדי מפתח (LQDA)

This indicator determines the portion of net income attributable to a single common share over a rolling year, excluding the impact of changes in capital structure. Analyzing the rolling annual earnings per share allows for an assessment of the commercialization efficiency of Liquidia Corporation (LQDA) inhalation drugs, separating fundamental profit growth from formal costs associated with environmental compliance and laboratory safety.